Difference between revisions 595893469 and 595896135 on enwiki

'''Zerona''' is a low-level laser device developed by Erchonia Corp. for non-invasive body slimming of the waist, hips, and thighs. It has been shown to disrupt [[adipocyte]], or fat cell, membranes causing the release of stored [[lipids]] and fatty material, in turn, promoting adipocyte collapse. The device was first introduced to the market in 2008 as an [[off-label use]] device for slimming, but later was granted 510k market clearance by the [[Food and Drug Administration]] (contracted; show full)ic photochemistry is defined by laws, and the first law of [[photochemistry]] states that a photoabsorbing structure must be present to yield a clinical outcome. [[Cytochrome c oxidase]], a terminal enzyme found within the [[electron transport chain]] of the [[mitochondria]], has been reported by Karu et al. (2010) to function as a photoabsorbing complex within eukaryotic cells ([[eukaryote]])<ref>{{cite web|url=http://www.accessdata.fda.gov/cdrh_docs/pdf7/K072206.pdf|publisher=Erchonia Medical Inc.|
title=Erchonia EML Laser|accessdate=17 February 2014|date=April 28|year=2008}}</ref> . This enzyme is responsible for facilitating the transport of electrons across the [[inner mitochondrial membrane]] to reduce oxygen and generate a proton [[electrochemical gradient]]. Cytochrome c oxidase serves an important role in the metabolic process known as [[oxidative phosphorylation]], which is the production of the high energy molecule [[adenosine triphosphate]] (ATP).<ref>{{cite book |first1=Reginald |last1=Garrett |first2=C(contracted; show full)==External links==
*[http://www.erchonia.com/ Erchonia Corp., Official Website]

== References ==
{{reflist|2}}

[[Category:Laser medicine]]
[[Category:Management of obesity]]